DeutschNewstral
Article
jdsupra.com on 2023-10-12 20:20
PMPRB adopts Amended Interim Guidance pending release of new guidelines
Related news
- Few significant changes made in final PMPRB Guidelinesjdsupra.com
- Innovators challenge final PMPRB Guidelines in new Federal Court applicationjdsupra.com
- PMPRB Updates: Definition of “Gap Medicine” amended, modified threshold for investigating the price of new patented medicinesjdsupra.com
- PMPRB Update: new consultation on PMPRB Guidelines, including revised international price testsjdsupra.com
- PMPRB releases draft Guidelines operationalizing amended Patented Medicines Regulationsjdsupra.com
- New PMPRB Guidelines will not be implemented January 1, 2023jdsupra.com
- 2021 PMPRB Annual Reportjdsupra.com
- Federal Court of Appeal dismisses appeal challenging amended basket of comparator countries in PMPRB Regulationsjdsupra.com
- Quebec Court finds price and revenue calculation provisions of amended PMPRB Regulations unconstitutionaljdsupra.com
- PMPRB posts submissions from Guidelines consultation; Federal Court challenge of amended Regulations rescheduledjdsupra.com
- PMPRB News: “significant changes” to be made to draft pricing Guidelinesjdsupra.com
- Draft revised PMPRB Guidelines released for comment by December 5, 2022jdsupra.com
- PMPRB news: Upcoming roundtable as first phase of new guidelines consultation, two new appointmentsjdsupra.com
- PMPRB publishes scoping paper for consultation on guidelines, and invites stakeholder feedbackjdsupra.com
- New PMPRB regulations registered, in force July 1, 2022, interim approach to pricing announcedjdsupra.com
- Final PMPRB Guidelines Releasedjdsupra.com
G-7 adopts financial-sector cybersecurity guidelinesThe Japan Times- PMPRB publishes annual Meds Pipeline Monitor reportjdsupra.com
- PMPRB releases three new NPDUIS reportsjdsupra.com
- PMPRB proposes to modify Guidelines definition of "gap medicine" to include medicines sold by July 1, 2021jdsupra.com